| 1 |
Zhu F, Li C, Chu F, Tian X, Zhu J. Target Dysbiosis of Gut Microbes as a Future Therapeutic Manipulation in Alzheimer's Disease. Front Aging Neurosci 2020;12:544235. [PMID: 33132894 DOI: 10.3389/fnagi.2020.544235] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 2 |
Jaeger V, DeMorrow S, McMillin M. The Direct Contribution of Astrocytes and Microglia to the Pathogenesis of Hepatic Encephalopathy. J Clin Transl Hepatol. 2019;7:352-361. [PMID: 31915605 DOI: 10.14218/jcth.2019.00025] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 3 |
Merino JJ, Cabaña-Muñoz ME, Toledano Gasca A, Garcimartín A, Benedí J, Camacho-Alonso F, Parmigiani-Izquierdo JM. Elevated Systemic L-Kynurenine/L-Tryptophan Ratio and Increased IL-1 Beta and Chemokine (CX3CL1, MCP-1) Proinflammatory Mediators in Patients with Long-Term Titanium Dental Implants. J Clin Med 2019;8:E1368. [PMID: 31480733 DOI: 10.3390/jcm8091368] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 4 |
Aller MA, Arias N, Blanco-Rivero J, Arias JL, Arias J. Hepatic encephalopathy: Sometimes more portal than hepatic. J Gastroenterol Hepatol 2019;34:490-4. [PMID: 30345537 DOI: 10.1111/jgh.14514] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 5 |
Aller MA, Arias N, Peral I, García-Higarza S, Arias JL, Arias J. Embrionary way to create a fatty liver in portal hypertension. World J Gastrointest Pathophysiol 2017; 8(2): 39-50 [PMID: 28573066 DOI: 10.4291/wjgp.v8.i2.39] [Reference Citation Analysis]
|
| 6 |
McMillin M, Grant S, Frampton G, Andry S, Brown A, DeMorrow S. Fractalkine suppression during hepatic encephalopathy promotes neuroinflammation in mice. J Neuroinflammation. 2016;13:198. [PMID: 27561705 DOI: 10.1186/s12974-016-0674-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 7 |
Arias N, Méndez M, Gómez-Lázaro E, Azpiroz A, Arias JL. Main target of minimal hepatic encephalopathy: Morphophysiological, inflammatory and metabolic view. Physiol Behav 2015;149:247-54. [PMID: 26079568 DOI: 10.1016/j.physbeh.2015.06.019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 8 |
Manti S, Marseglia L, D'Angelo G, Filippelli M, Cuppari C, Gitto E, Romano C, Arrigo T, Salpietro C. Portal hypertension as immune mediate disease. Hepat Mon 2014;14:e18625. [PMID: 24976841 DOI: 10.5812/hepatmon.18625] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
